233 related articles for article (PubMed ID: 21146937)
21. Quetiapine for primary insomnia: a double blind, randomized controlled trial.
Tassniyom K; Paholpak S; Tassniyom S; Kiewyoo J
J Med Assoc Thai; 2010 Jun; 93(6):729-34. PubMed ID: 20572379
[TBL] [Abstract][Full Text] [Related]
22. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
Vaishnavi S; Alamy S; Zhang W; Connor KM; Davidson JR
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1464-9. PubMed ID: 17698275
[TBL] [Abstract][Full Text] [Related]
23. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
[TBL] [Abstract][Full Text] [Related]
24. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
[TBL] [Abstract][Full Text] [Related]
25. Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes.
Monti PM; Rohsenow DJ; Swift RM; Gulliver SB; Colby SM; Mueller TI; Brown RA; Gordon A; Abrams DB; Niaura RS; Asher MK
Alcohol Clin Exp Res; 2001 Nov; 25(11):1634-47. PubMed ID: 11707638
[TBL] [Abstract][Full Text] [Related]
26. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients.
Baltieri DA; Daró FR; Ribeiro PL; Andrade AG
Drug Alcohol Depend; 2009 Nov; 105(1-2):33-41. PubMed ID: 19595518
[TBL] [Abstract][Full Text] [Related]
27. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
28. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
Ait-Daoud N; Johnson BA; Javors M; Roache JD; Zanca NA
Alcohol Clin Exp Res; 2001 Jun; 25(6):847-9. PubMed ID: 11410720
[TBL] [Abstract][Full Text] [Related]
29. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
[TBL] [Abstract][Full Text] [Related]
30. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
Sussman N; Mullen J; Paulsson B; Vågerö M
J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
[TBL] [Abstract][Full Text] [Related]
31. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
[TBL] [Abstract][Full Text] [Related]
32. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
[TBL] [Abstract][Full Text] [Related]
33. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP
J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604
[TBL] [Abstract][Full Text] [Related]
34. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
[TBL] [Abstract][Full Text] [Related]
35. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
[TBL] [Abstract][Full Text] [Related]
36. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
37. Comparing topiramate with naltrexone in the treatment of alcohol dependence.
Baltieri DA; Daró FR; Ribeiro PL; de Andrade AG
Addiction; 2008 Dec; 103(12):2035-44. PubMed ID: 18855810
[TBL] [Abstract][Full Text] [Related]
38. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
Younger J; Noor N; McCue R; Mackey S
Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
[TBL] [Abstract][Full Text] [Related]
39. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
[TBL] [Abstract][Full Text] [Related]
40. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
